El modelo de calidad de vida y apoyosla unión tras veinticinco años de caminos paralelos

  1. Verdugo Alonso, Miguel Ángel 1
  2. Schalock, Robert L. 2
  3. Gómez Sánchez, Laura E. 3
  1. 1 Universidad de Salamanca
    info

    Universidad de Salamanca

    Salamanca, España

    ROR https://ror.org/02f40zc51

  2. 2 Universidad de Nebraska
  3. 3 Universidad de Oviedo
    info

    Universidad de Oviedo

    Oviedo, España

    ROR https://ror.org/006gksa02

Show affiliations +
Journal:
Siglo Cero: Revista Española sobre Discapacidad Intelectual

ISSN: 2530-0350

Year of publication: 2021

Volume: 52

Issue: 3

Pages: 9-28

Type: Article

DOI: 10.14201/SCERO2021523928 DIALNET GOOGLE SCHOLAR lock_openOpen access editor

More publications in: Siglo Cero: Revista Española sobre Discapacidad Intelectual

Abstract

The article presents the operational conjunction of the quality of life and supports paradigms in the new Quality of Life Supports Model (QOLSM) that integrates significant characteristics of the current transformation in the field of intellectual and developmental disabilities. These characteristics encompass a holistic and integrated approach, an approach focused on the human and legal rights of people with disabilities, eligibility for services and supports based on significant limitations in major areas of life activity, an emphasis on supports provided within inclusive community settings, and outcome assessment. The objectives of this article are to describe and indicate: (a) the four elements of the MOCA (fundamental values, individual and family quality of life domains, support systems and facilitating conditions); (b) how the MOCA can be used as a framework for the provision of supports, person-centered outcome assessment, organizational transformation and systems change; and (c) how MOCA is essential to the current paradigm shift in the field of Intellectual and Developmental Disabilities.

Bibliographic References

  • Evereklioglu C. Primary Probing with and without Monoka Silastic Stent Intubation for Epiphora in Older Children and Adults. Curr Eye Res. 2020;45(1):87–90.
  • Toti A. Nuovo metodo conservative di cura radicale delle suporazioni chroniche del sacco lacrimale. Clin Mod Firenze. 1904;10:385–9.
  • Dupuy-Dutemps L, Bourguet J. Procede plastique de dacryocystorhinostomie et ses resultats. Ann Ocul J. 1921;72:241–61.
  • Tarbet KJ, Custer PL. External Dacryocystorhinostomy: Surgical Success, Patient Satisfaction, and Economic Cost. Ophthalmology. 1995;102(7):1065–70.
  • Fayers T, Laverde T, Tay E, Olver JM. Lacrimal surgery success after external dacryocystorhinostomy: Functional and anatomical results using strict outcome criteria. Ophthal Plast Reconstr Surg. 2009;25(6):472–5.
  • Ali M, Naik M, Honavar S. External dacryocystorhinostomy: Tips and tricks. Oman J Ophthalmol. 2012;5(3):191–5.
  • Toledano Fernández N. Tratamiento quirúrgico de las obstrucciones del conducto nasolagrimal. Dacriocistorrinostomía por vía externa. indicaciones, técnica y complicaciones. Dacriocistectomía. Manejo actual de las obstrucciones del conducto nasolagrimal. 2001.
  • Davies BW, McCracken MS, Hawes MJ, Hink EM, Durairaj VD, Pelton RW. Tear Trough Incision for External Dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2015;31(4):278–81.
  • Akaishi PMS, Mano JB, Pereira IC, Cruz AAVE. Functional and cosmetic results of a lower eyelid crease approach for external dacryocystorhinostomy. Arq Bras Oftalmol. 2011;74(4):283–5.
  • Wadwekar B, Hansdak A, Nirmale SD, Ravichandran K. Cutaneous scar visibility after external dacryocystorhinostomy: A comparison of curvilinear and W shaped incision. Saudi J Ophthalmol. 2019;33(2):142–7.
  • Ng DSC, Chan E. Techniques to minimize skin incision scar for external dacryocystorhinostomy. Orbit. 2016;35(1):42–5.
  • Harris GJ, Sakol PJ BR. Relaxed skin tension line incision for dacryocystorhinostomy. Am J Ophthalmol. 1989;15;108(6):742–3.
  • Takahashi Y, Nakamura Y, Kakizaki H. Eight-flap anastomosis in external dacryocystorhinostomy. Br J Ophthalmol. 2015;99(11):1527–30.
  • Galindo-Ferreiro A, Dufaileej M, Galvez-Ruiz A, Khandekar R, Schellini SA. Characteristics and success rates of same day or asynchronous bilateral external dacryocystorhinostomy. J Craniofac Surg. 2019;30(4):1184–6.
  • Pandya VB, Lee S, Benger R, Danks JJ, Kourt G, Martin PA, et al. The role of mucosal flaps in external dacryocystorhinostomy. Orbit. 2010;29(6):324–7.
  • Kaçaniku G, Begolli I. External dacryocystorhinostomy with and without suturing the posterior mucosal flaps. Med Arh. 2014;68(1):54–6.
  • Serin D, Alagöz G, Karsloǧlu Ş, Çelebi S, Kükner Ş. External dacryocystorhinostomy: Double-flap anastomosis or excision of the posterior flaps? Ophthal Plast Reconstr Surg. 2007;23(1):28–31.
  • Takahashi Y, Mito H, Kakizaki H. External dacryocystorhinostomy with or without double mucosal flap anastomosis: Comparison of surgical outcomes. J Craniofac Surg. 2015;26(4):1290–3.
  • Yazici B, Akova B. Simultaneous bilateral external dacryocystorhinostomy. Acta Ophthalmol Scand. 2007;85(6):667–70.
  • Sarode D, Bari DA, Cain AC, Syed MI, Williams AT. The benefit of silicone stents in primary endonasal dacryocystorhinostomy: a systematic review and meta-analysis. Clin Otolaryngol. 2017;42(2):307–14.
  • Ari Ş, Gun R, Surmeli S, Atay AE, Çaca Î. Use of adjunctive mitomycin C in external dacryocystorhinostomy surgery compared with surgery alone in patients with nasolacrimal duct obstruction: A prospective, double-masked, randomized, controlled trial. Curr Ther Res - Clin Exp. 2009;70(4):267–73.
  • Nair AG, Ali MJ. Mitomycin-C in dacryocystorhinostomy: From experimentation to implementation and the road ahead: A review. Indian J Ophthalmol. 2015;63(4):335–9.
  • Alañón Fernández MÁ, Alañón Fernández FJ, Martínez Fernández A, Cárdenas Lara M. Resultados de la aplicación de mitomicina en la dacriocistorrinostomía endonasal y endocanalicular con láser diodo. Acta Otorrinolaringol Esp. 2006;57(8):355–8.
  • Mukhtar SA, Jamil AZ, Ali Z. Efficacy of external dacryocystorhinostomy (DCR) with and without mitomycin-C in chronic dacryocystitis. J Coll Physicians Surg Pakistan. 2014;24(10):732–5.
  • Atkova EL, Fedorov AA, Root AO, Iartsev SD, Krakhovetsky NN, Yartsev VD. Causes of unsatisfactory results of the use of mitomycin-C in endoscopic endonasal dacryocystorhinostomy. Saudi J Ophthalmol. 2017;31(3):150–5.
  • Yeatts RP NR. Use of mitomycin C in repeat dacryocystorhinostomy. Ophthalmic Plast Reconstr Surgeryphthalmic Plast Reconstr Surg. 1999;15(1):19–22.
  • You YA FC. Intraoperative mitomycin C in dacryocystorhinostomy. Ophthalmic Plast Reconstr Surg. 2001;17(2):115–9.
  • Gonzalvo Ibáñez FJ, Fuertes Fernández I, Fernández Tirado FJ, Hernández Delgado G, Rabinal Arbués F HLF. Dacriocistorrinostomía externa con mitomicina C. Valoración clínica y anatómica mediante tomografía computarizada helicoidal [External dacryocystorhinostomy with mitomycin C. Clinical and anatomical evaluation with helical computed tomography]. Arch Soc Esp Oftalmol. 2000;75(9):611–7.
  • Liao SL, Kao SC, Tseng JH, Chen MS HP. Results of intraoperative mitomycin C application in dacryocystorhinostomy. Br J Ophthalmol. 2000;84(8):903–6.
  • McNab AA. Dacryocystorhinostomy. Manual of Orbital and Lacrimal Surgery. 1998.
  • Lee MJ, Park J, Yang MK, Choi YJ, Kim N, Choung HK, et al. Long-term results of maintenance of lacrimal silicone stent in patients with functional epiphora after external dacryocystorhinostomy. Eye. 2020;34(4):669–74.
  • Boboridis KG, Bunce C, Rose GE. Outcome of external dacryocystorhinostomy combined with membranectomy of a distal canalicular obstruction. Am J Ophthalmol. 2005;139(6):1051–6.
  • Syed MI, Head EJ, Madurska M, Hendry J, Erikitola OC, Cain AJ. Endoscopic primary dacryocystorhinostomy: Are silicone tubes needed? Our experience in sixty three patients. Clin Otolaryngol. 2013;38(5):406–10.
  • Bohman E, Dafgård Kopp E. One-week intubation in external dacryocystorhinostomy– a report on long-term outcome. Orbit (London). 2020 DOI: 10.1080/01676830.2020.1778737
  • Shun-Shin GA, Thurairajan G. External dacryocystorhinostomy - an end of an era? Br J Ophthalmol. 1997;81(9):716–7.
  • Sharma V, Martin PA, Benger R, Kourt G, Danks JJ, Deckel Y, et al. Evaluation of the cosmetic significance of external dacryocystorhinostomy scars. Am J Ophthalmol. 2005;140(3):359.e1-359.e7.
  • Devoto MH, Zaffaroni MC, Bernardini FP, De Conciliis C. Postoperative evaluation of skin incision in external dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2004;20(5):358–61.
  • Caesar RH, Fernando G, Scott K, McNab AA. Scarring in external dacryocystorhinostomy: Fact or fiction? Orbit. 2005;24(2):83–6.
  • Chisty N, Singh M, Ali MJ, Naik MN. Long-term outcomes of powered endoscopic dacryocystorhinostomy in acute dacryocystitis. Laryngoscope. 2016;126(3):551–3.
  • Li EY, Wong ES, Wong AC, Yuen HK. Primary vs secondary endoscopic dacryocystorhinostomy for acute dacryocystitis with lacrimal sac abscess formation a randomized clinical trial. JAMA Ophthalmol. 2017;135(12):1361–6.
  • Jones LT. Conjunctivodacryocystorhinostomy. Am J Ophthalmol. 2018;187:xxxvi–xliv.
  • Alañón Fernández MÁ, Alañón Fernández FJ, Martínez Fernández A, Cárdenas Lara M. Conjuntivodacriocistorrinostomía con láser diodo. Inserción endoscópica de tubos de Jones. Acta Otorrinolaringol Esp. 2008;59(1):11–5.
  • Can I, Can B, Yarangümeli A, Gürbüz O, Tekelioglu M KG. CDCR with buccal mucosal graft: comparative and histopathological study. Ophthalmic Surg Lasers. 1999;30(2):98–104.
  • Lim C, Martin P, Benger R, Kourt G, Ghabrial R. Lacrimal canalicular bypass surgery with the Lester Jones tube. Am J Ophthalmol. 2004;137(1):101–8.
  • Ahn ES, Dailey RA, Radmall B. The Effectiveness and Long-Term Outcome of Conjunctivodacryocystorhinostomy with Frosted Jones Tubes. Ophthal Plast Reconstr Surg. 2017;33(4):294–9.
  • Chang M, Lee H, Park M, Baek S. Long-term outcomes of endoscopic endonasal conjunctivodacryocystorhinostomy with Jones tube placement: A thirteen-year experience. J Cranio-Maxillofacial Surg. 2015;43(1):7–10.
  • Devoto MH, Bernardini FP, De Conciliis C. Minimally invasive conjunctivodacryocystorhinostomy with Jones tube. Ophthal Plast Reconstr Surg. 2006;22(4):253–5.
  • Mohammad Javed A. Conjunctivodacryocystorhinostomy: Indications, techniques and complications. Principles and practice of lacrimal surgery. Springer; 2015; pp 291–302.
  • Steele EA. Conjunctivodacryocystorhinostomy with Jones tube: A history and update. Curr Opin Ophthalmol. 2016;27(5):439–42.
  • Trotter WL, Meyer DR. Endoscopic conjunctivodacryocystorhinostomy with Jones tube placement. Ophthalmology. 2000;107(6):1206–9.
  • Bagdonaite L, Pearson AR. Twelve-Year Experience of Lester Jones Tubes - Results and Comparison of 3 Different Tube Types. Ophthal Plast Reconstr Surg. 2015;31(5):352–6.
  • Timlin HM, Jiang K, Mathewson P, Manta A, Rubinstein T, Ezra DG. Long-Term Outcomes of StopLoss Jones Tubes for Epiphora in Patients with Early or Multiple Loss of Lester Jones Tubes. Ophthal Plast Reconstr Surg. 2020;XX(XX):127–31.
  • Kakizaki H. The rate of symptomatic improvement of congenital nasolacrimal duct obstruction in Japanese infants treated with conservative management during the 1st year of age. Clin Ophthalmol. 2008;3311(ext 2181):291.
  • Kashkouli MB, Kassaee A, Tabatabaee Z. Initial nasolacrimal duct probing in children under age 5: Cure rate and factors affecting success. J AAPOS. 2002;6(6):360–3.
  • Schellini SA, Narikawa S, Ribeiro SCF, Nakagima V, Padovani CR, Padovani CRP. Congenital lacrimal obstruction: outcome and factors associated with therapeutic probing. Arq Bras Oftalmol. 2005 Oct;68(5):627–30.
  • Nucci P, Capoferri C, Alfarano R BR. Conservative management of congenital nasolacrimal duct obstruction. J Pediatr Ophthalmol Strabismus. 1989;26(1):39–43.
  • Karti O, Karahan E, Acan D, Kusbeci T. The natural process of congenital nasolacrimal duct obstruction and effect of lacrimal sac massage. Int Ophthalmol. 2016;36(6):845–9.
  • Eye P, Investigator D. Primary Treatment of Nasolacrimal Duct Obstruction with Probing in Children Younger than 4 Years. Ophthalmology. 2008;115(3). DOI: 10.1016/j.ophtha.2007.07.030
  • Galindo-Ferreiro A, Khandekar R, Akaishi PM, Cruz A, Gálvez-Ruiz A, Dolmetsch A, et al. Success Rates of Endoscopic-Assisted Probing Compared to Conventional Probing in Children 48 Months or Older. Semin Ophthalmol. 2018;33(3):435–42.
  • Wallace EJ, Cox A, White P, MacEwen CJ. Endoscopic-assisted probing for congenital nasolacrimal duct obstruction. Eye. 2006;20(9):998–1003.
  • Galindo-Ferreiro A, Akaishi P, Cruz A, Khandekar R, Dossari S, Dufaileej M, Galvez-Ruiz A SS. Success Rates of Conventional Versus Endoscope-Assisted Probing for Congenital Nasolacrimal Duct Obstruction in Children 12 Years and Younger. J Pediatr Ophthalmol Strabismus2. 2016;1;53(5):292–2.
  • Kapadia MK, Freitag SK, Woog JJ. Evaluation and Management of Congenital Nasolacrimal Duct Obstruction. Otolaryngol Clin North Am. 2006;39(5):959–77.
  • Eye P, Investigator D, Lee KA, Danielle L, Repka MX, Beck RW, et al. A randomized trial comparing the cost-effectiveness of 2 approaches for treating unilateral nasolacrimal duct obstruction. Arch Ophthalmol. 2013;130(March 2012):1525–33.
  • Honavar SG, Prakash VE, Rao GN. Outcome of probing for congenital nasolacrimal duct obstruction in older children. Am J Ophthalmol. 2000;130(1):42–8.
  • Kashkouli MB, Beigi B, Parvaresh MM, Kassaee A, Tabatabaee Z. Late and very late initial probing for congenital nasolacrimal duct obstruction: What is the cause of failure? Br J Ophthalmol. 2003;87(9):1151–3.
Data source: Dialnet